Literature DB >> 18486616

Unraveling the role of PD-1/PD-L interactions in persistent hepatotropic infections: potential for therapeutic application?

Henry Radziewicz, Holly L Hanson, Rafi Ahmed, Arash Grakoui.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18486616     DOI： 10.1053/j.gastro.2008.04.012

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  11 in total

1.  Regulatory T cells use programmed death 1 ligands to directly suppress autoreactive B cells in vivo.

Authors:  Janine Gotot; Catherine Gottschalk; Sonny Leopold; Percy A Knolle; Hideo Yagita; Christian Kurts; Isis Ludwig-Portugall
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-11       Impact factor: 11.205

2.  Toso regulates differentiation and activation of inflammatory dendritic cells during persistence-prone virus infection.

Authors:  P A Lang; A Meryk; A A Pandyra; D Brenner; A Brüstle; H C Xu; K Merches; F Lang; V Khairnar; P Sharma; P Funkner; M Recher; N Shaabani; G S Duncan; V Duhan; B Homey; P S Ohashi; D Häussinger; P A Knolle; N Honke; T W Mak; K S Lang
Journal:  Cell Death Differ       Date:  2014-09-26       Impact factor: 15.828

3.  Effects of antiviral therapy with Telbivudine on peripheral iNKT cells in HBeAg(+) chronic hepatitis B patients.

Authors:  T D Shi; J M Zhang; X F Wang; M Chen; H Sun; C B Chen; H Ren
Journal:  Clin Exp Med       Date:  2011-07-12       Impact factor: 3.984

4.  Alternative serotype adenovirus vaccine vectors elicit memory T cells with enhanced anamnestic capacity compared to Ad5 vectors.

Authors:  Pablo Penaloza-MacMaster; Nicholas M Provine; Joshua Ra; Erica N Borducchi; Anna McNally; Nathaniel L Simmons; Mark J Iampietro; Dan H Barouch
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

5.  Isolation of Neutralizing Human Single Chain Antibodies Against Conserved Hemagglutinin Epitopes of Influenza a Virus H3N2 Strain.

Authors:  Mahboubeh Poursiami; Setareh Moazen; Foroogh Nejatollahi; Afagh Moatari
Journal:  Rep Biochem Mol Biol       Date:  2019-10

6.  Conserved Motifs within Hepatitis C Virus Envelope (E2) RNA and Protein Independently Inhibit T Cell Activation.

Authors:  Nirjal Bhattarai; James H McLinden; Jinhua Xiang; Thomas M Kaufman; Jack T Stapleton
Journal:  PLoS Pathog       Date:  2015-09-30       Impact factor: 6.823

7.  Hepatitis C virus infection inhibits a Src-kinase regulatory phosphatase and reduces T cell activation in vivo.

Authors:  Nirjal Bhattarai; James H McLinden; Jinhua Xiang; M Meleah Mathahs; Warren N Schmidt; Thomas M Kaufman; Jack T Stapleton
Journal:  PLoS Pathog       Date:  2017-02-24       Impact factor: 6.823

Review 8.  Monoclonal antibody-based therapies for microbial diseases.

Authors:  Carolyn Saylor; Ekaterina Dadachova; Arturo Casadevall
Journal:  Vaccine       Date:  2009-12-30       Impact factor: 3.641

9.  Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade.

Authors:  Nobuhiro Nakamoto; Hyosun Cho; Abraham Shaked; Kim Olthoff; Mary E Valiga; Mary Kaminski; Emma Gostick; David A Price; Gordon J Freeman; E John Wherry; Kyong-Mi Chang
Journal:  PLoS Pathog       Date:  2009-02-27       Impact factor: 6.823

10.  A heterologous prime/boost vaccination strategy enhances the immunogenicity of therapeutic vaccines for hepatitis C virus.

Authors:  Anne Fournillier; Lars Frelin; Emilie Jacquier; Gustaf Ahlén; Anette Brass; Estelle Gerossier; Fredrik Holmström; Kate E Broderick; Niranjan Y Sardesai; Jean-Yves Bonnefoy; Geneviève Inchauspé; Matti Sällberg
Journal:  J Infect Dis       Date:  2013-06-17       Impact factor: 5.226
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.